Pre-Open Stock Movers 3/11: (LJPC) (BYD) (FCEL) Higher; (FTEK) (RTK) (MYGN) Lower (more...)
Tweet Send to a Friend
La Jolla Pharmaceutical Company. (NASDAQ: LJPC) 69% HIGHER; announced positive top-line results from its randomized, placebo-controlled Phase 2 trial of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE